PreDxion Bio

About:

PreDxion Bio is revolutionizing testing and treatment through low-cost, user-friendly at-home diagnostics.

Top Investors: University of Michigan, Y Combinator, SignalFire, MedTech Innovator, Hillsven Capital

Description:

PreDxion Bio is an early-stage healthcare company revolutionizing testing and treatment through low-cost, user-friendly at-home diagnostics. Enabled by PreDxion’s proprietary multiplexed localized surface plasmon resonance (LSPR) technology, our first product is a rapid, saliva-based test for COVID-19, flu, pneumonia, common cold, and other respiratory diseases.

Total Funding Amount:

$6.37M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2016-02-02

Contact Email:

walker.mchugh(AT)predxionbio.com

Founders:

Caroline Landau, Tim Cornell, Walker McHugh

Number of Employees:

1-10

Last Funding Date:

2020-09-15

IPO Status:

Private

Industries: